May 2019 - Fast Stats

April 25, 2019

On April 12, FDA made an update to its December 2018 Safety Communication about the results it received from post-market surveillance studies (“522 studies”) on duodenoscopes used in Endoscopic Retrograde Cholangiopancreatography procedures (ERCP). As reports of duodenoscope-related infections declined 62 percent to fewer than 100 in 2017, the agency assumed the studies would yield less than a 0.4 percent contamination rate. According to preliminary results, they saw much higher-than-expected levels of contamination.

3

people died in the United States in 2018 from duodenoscope-related infections.

45

incidents of patient infection related to duodenoscopes were reported last year.

159

device contamination reports were made in 2018.

3.6%

of properly collected samples tested positive for low to moderate concern organisms with >100 CFU.

5.4%

of properly collected samples test positive for high concern organisms, defined as organisms that are more often associated with disease, such as E. coli, and Pseudomonas aeruginosa, a 3% increased contamination rate than previously reported.

Source: FDA Safety Communication, April 12, 2019.

ID 121363340 © Kasto80 | Dreamstime.com
dreamstime_xxl_121363340
ID 95151078 © Marek Uliasz | Dreamstime.com
dreamstime_xxl_95151078
ID 9085250 | Hospital © Hongqi Zhang (aka Michael Zhang) | Dreamstime.com
dreamstime_xxl_9085250
ID 244539567 © Wave Break Media Ltd | Dreamstime.com
dreamstime_xxl_244539567